Evaluate Safety, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of BCD-261 After Single Subcutaneous Injection in Healthy Chinese Volunteers
Clinical trial NCT07535775 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07535775
- Sponsor
- SPH-BIOCAD (HK) Limited
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-11
- Primary completion
- 2026-10-10
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.